Advertisement
Screener

ZIMMER BIOMET HOLDINGS, INC. (ZBH) Gain (Loss) on Investments

1.7 / 5 stars · 36/109 Roast Me

ZIMMER BIOMET HOLDINGS, INC. Gain (Loss) on Investments

ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Gain (Loss) on Investments of $14.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.

Financial Statements › Income Statement › Other Income

us-gaap:GainLossOnInvestments · last filed 2026-02-20

  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for the quarter ending 2023-12-31 was -$21.00M.
  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for the quarter ending 2023-09-30 was $0.00.
  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for the quarter ending 2023-06-30 was $0.00.
  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for the quarter ending 2023-03-31 was $2.50M.
  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for fiscal 2025 was $14.70M.
  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for fiscal 2024 was -$42.10M.
  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for fiscal 2023 was -$18.50M.
  • ZIMMER BIOMET HOLDINGS, INC. gain (loss) on investments for fiscal 2022 was -$116.60M.
Period endGain (Loss) on Investments 3 monthGain (Loss) on Investments 6 monthGain (Loss) on Investments 9 monthGain (Loss) on Investments 12 monthGain (Loss) on Investments 12 month as first filed
2025-12-31$14.70M
10-K · filed 2026-02-20
2024-12-31-$42.10M
10-K · filed 2026-02-20
$0.00
10-K · filed 2025-02-25
2023-12-31-$21.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
-$21.00M
derived: sum of 2 quarters · filed 2026-02-20
-$21.00M
derived: sum of 3 quarters · filed 2026-02-20
-$18.50M
10-K · filed 2026-02-20
$2.50M
10-K · filed 2024-02-23
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$0.00
derived: sum of 2 quarters · filed 2023-11-07
$2.50M
10-Q · filed 2023-11-07
$200.00K
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$2.50M
10-Q · filed 2023-08-01
$200.00K
derived: sum of 3 quarters · filed 2025-02-25
-$29.80M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$2.50M
10-Q · filed 2023-05-02
$200.00K
derived: sum of 2 quarters · filed 2025-02-25
-$29.80M
derived: sum of 3 quarters · filed 2025-02-25
-$63.10M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$32.30M
derived: sum of 2 quarters · filed 2025-02-25
-$65.60M
derived: sum of 3 quarters · filed 2025-02-25
-$116.60M
10-K · filed 2025-02-25
2022-09-30-$30.00M
10-Q · filed 2023-11-07
-$63.30M
derived: sum of 2 quarters · filed 2023-11-07
-$114.30M
10-Q · filed 2023-11-07
2022-06-30-$33.30M
10-Q · filed 2023-08-01
-$84.30M
10-Q · filed 2023-08-01
2022-03-31-$51.00M
10-Q · filed 2023-05-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B